Publisher's Synopsis
The development of antiviral drugs has become a critical part of public health efforts, especially in the context of global viral outbreaks. Nations continue adopting diverse strategies to combat viral infections, shaped by differences in scientific infrastructure, regulatory frameworks, economics, and public health priorities. While high-income countries often lead in drug discovery and clinical trials, lower- and middle-income nations contribute through data and innovative approaches. This global perspective shows the importance of international collaboration and equitable access in the development, testing, and distribution of antiviral therapies. Global Perspectives on Antiviral Drug Development explores the global landscape of antiviral drug development, deployment, and management. It offers an in-depth look at how different countries and regions around the world tackle viral threats, with a strong emphasis on the strategies that shape public health and the innovations driving the future of antiviral treatments. This book covers topics such as vaccines, pharmacology, and personalized medicine, and is a useful resource for medical and healthcare professionals, engineers, academicians, researchers, and scientists.
